Andrea Flynn | Investor Relations |
Bruce Cozadd | Chairman and Chief Executive Officer |
Renee Gala | Executive Vice President and Chief Financial Officer |
Dan Swisher | President |
Rob Iannone | Executive Vice President-R&D and Chief Medical Officer |
Ken Cacciatore | Cowen and Company |
Jessica Fye | JPMorgan |
Jason Gerberry | Bank of America |
Melina Santoro | Morgan Stanley |
David Amsellem | Piper Sandler |
Gary Nachman | BMO Capital Markets |
Annabel Samimy | Stifel |
Esther Rajavelu | UBS |
Marc Goodman | SVB Leerink |
Graig Suvannavejh | Goldman Sachs |
David Steinberg | Jefferies |
Balaji Prasad | Barclays |
Good day and thank you for standing-by. Welcome to the Second Quarter 2021 Jazz Pharmaceuticals Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Andrea Flynn. Please go ahead.